CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
153 hedge funds and large institutions have $200M invested in Clovis Oncology, Inc. in 2019 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 66 increasing their positions, 33 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
153
Holders Change
-14
Holders Change %
-8.38%
% of All Funds
3.36%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
25
Increased
66
Reduced
33
Closed
39
Calls
$28.4M
Puts
$23.8M
Net Calls
+$4.6M
Net Calls Change
-$53.1M
Top Buyers
| 1 |
ECP
1
Elk Creek Partners
Denver,
Colorado
|
$12.1M |
| 2 |
2
Capital World Investors
Los Angeles,
California
|
$13.5M |
| 3 |
3
Morgan Stanley
New York
|
$8.26M |
| 4 |
4
Two Sigma Investments
New York
|
$4.19M |
| 5 |
5
D.E. Shaw & Co
New York
|
$6.93M |
Top Sellers
| 1 |
O
1
OrbiMed
New York
|
$0 |
| 2 |
2
State Street
Boston,
Massachusetts
|
$3.9M |
| 3 |
SC
3
Samlyn Capital
New York
|
$0 |
| 4 |
4
Balyasny Asset Management
Chicago,
Illinois
|
$0 |
| 5 |
5
Rafferty Asset Management
New York
|
$0 |
